Erika Molignano
Sr. Director of Quality Assurance at Decibel Therapeutics - Boston, Massachusetts, US
Erika Molignano's Colleagues at Decibel Therapeutics
Elisabeth Leiderman
Chief Financial Officer & Head of Corporate Development
Erika Molignano's Contact Details
(617) 370-8701
Boston,Massachusetts,United States
Decibel Therapeutics
Erika Molignano's Company Details
Decibel Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, one of the largest areas of unmet need in medicine. Decibel has built a proprietary platform that integrates single-cell genomics and bioinformatic analyses, precision gene therapy technologies and expertise in inner ear biology. Decibel is leveraging its platform to advance gene therapies designed to selectively replace genes for the treatment of congenital, monogenic hearing loss and to regenerate inner ear hair cells for the treatment of acquired hearing and balance disorders. Decibel’s pipeline, including its lead gene therapy program, DB-OTO, to treat congenital, monogenic hearing loss, is designed to deliver on our vision of building a world of connection for people with hearing and balance disorders. Guidelines: https://bit.ly/3IzmNvU